Cerebral Venous Thrombosis Cerebral venous thrombosis is characterized by infarction with
focal neurologic deficits and increased intracranial pressure. As a very rare complication of …

Aim Stroke is the leading cause of disability and death in China. Ischaemic stroke accounts
for about 60%–80% of all strokes. It is of considerable significance to carry out …

Background: A small randomized controlled trial suggested that dabigatran may be as
effective as warfarin in the treatment of cerebral venous thrombosis (CVT). We aimed to …

Currently licenced direct oral anticoagulants selectively target thrombin (eg, dabigatran) or
coagulation factor Xa (eg, apixaban, betrixaban, edoxaban, and rivaroxaban). Designed to …

Objective Identify clinical and radiographic features of venous infarct as a presenting feature
of COVID-19 in the young. Background SARS-CoV-2 infection causes hypercoagulability …

This consensus document is proposed to clinicians to provide the whole spectrum of deep
vein thrombosis management as an update to the 2017 consensus document. New data …

Anticoagulant treatment of pediatric cerebral venous thrombosis has not been evaluated in
randomized trials. We evaluated the safety and efficacy of rivaroxaban and standard …

Guidelines currently favor vitamin K antagonists or low-molecular-weight heparins for
treatment of noncirrhotic portal vein thrombosis (ncPVT). Use of direct oral anticoagulants …

Background: Recent studies have noted concern for increased thromboembolic events in
the setting of Coronavirus Disease 2019 (COVID-19). Cerebral venous sinus thrombosis …

All neurologists need to be able to recognise and treat cerebral venous thrombosis (CVT). It
is difficult to diagnose, partly due to its relative rarity, its multiple and various clinical …